CD44 and cancer: Hyaluronic acid (HYA) is well known as a CD44-targeting ligand and has frequently been used to decorate the nanoparticle surface for delivery to CD44-overexpressed cancer cells owing to its specificity toward CD44 receptors [22,23,24,25].